Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 309

1.

FIGO 2018 stage IB2 (2-4 cm) Cervical cancer treated with Neo-adjuvant chemotherapy followed by fertility Sparing Surgery (CONTESSA); Neo-Adjuvant Chemotherapy and Conservative Surgery in Cervical Cancer to Preserve Fertility (NEOCON-F). A PMHC, DGOG, GCIG/CCRN and multicenter study.

Plante M, van Trommel N, Lheureux S, Oza AM, Wang L, Sikorska K, Ferguson SE, Han K, Amant F.

Int J Gynecol Cancer. 2019 May 17. pii: ijgc-2019-000398. doi: 10.1136/ijgc-2019-000398. [Epub ahead of print]

PMID:
31101688
2.

Addition of IMP3 to L1CAM for discrimination between low- and high-grade endometrial carcinomas: an ENITEC collaboration study.

Visser NCM, van der Putten LJM, van Egerschot A, Van de Vijver KK, Santacana M, Bronsert P, Hirschfeld M, Colas E, Gil-Moreno A, Garcia A, Mancebo G, Alameda F, Krakstad C, Tangen IL, Huvila J, Schrauwen S, Koskas M, Walker F, Weinberger V, Minar L, Hausnerova J, Snijders MPLM, van den Berg-van Erp S, Matias-Guiu X, Trovik J, Amant F, Massuger LFAG, Bulten J, Pijnenborg JMA.

Hum Pathol. 2019 May 2. pii: S0046-8177(19)30079-6. doi: 10.1016/j.humpath.2019.04.014. [Epub ahead of print]

PMID:
31054899
3.

Poor outcome in hypoxic endometrial carcinoma is related to vascular density.

Reijnen C, van Weelden WJ, Arts MSJP, Peters JP, Rijken PF, van de Vijver K, Santacana M, Bronsert P, Bulten J, Hirschfeld M, Colas E, Gil-Moreno A, Reques A, Mancebo G, Krakstad C, Trovik J, Haldorsen IS, Huvila J, Koskas M, Weinberger V, Minar L, Jandakova E, Snijders MPLM, van den Berg-van Erp S, Küsters-Vandevelde HVN, Matias-Guiu X, Amant F; ENITEC-consortium, Massuger LFAG, Bussink J, Pijnenborg JMA.

Br J Cancer. 2019 Apr 23. doi: 10.1038/s41416-019-0461-2. [Epub ahead of print]

PMID:
31011231
4.

Characteristics of patients with cervical cancer during pregnancy: a multicenter matched cohort study. An initiative from the International Network on Cancer, Infertility and Pregnancy.

Halaska MJ, Uzan C, Han SN, Fruscio R, Dahl Steffensen K, Van Calster B, Stankusova H, Delle Marchette M, Mephon A, Rouzier R, Witteveen PO, Vergani P, Van Calsteren K, Rob L, Amant F.

Int J Gynecol Cancer. 2019 Mar 20. pii: ijgc-2018-000103. doi: 10.1136/ijgc-2018-000103. [Epub ahead of print]

PMID:
30898935
5.

Transplacental transport of paracetamol and its phase II metabolites using the ex vivo placenta perfusion model.

Conings S, Tseke F, Van den Broeck A, Qi B, Paulus J, Amant F, Annaert P, Van Calsteren K.

Toxicol Appl Pharmacol. 2019 May 1;370:14-23. doi: 10.1016/j.taap.2019.03.004. Epub 2019 Mar 5.

PMID:
30849458
6.

A Phase 2 Study to Assess the Immunomodulatory Capacity of a Lecithin-based Delivery System of Curcumin in Endometrial Cancer.

Tuyaerts S, Rombauts K, Everaert T, Van Nuffel AMT, Amant F.

Front Nutr. 2019 Jan 11;5:138. doi: 10.3389/fnut.2018.00138. eCollection 2018.

7.

Management of cancer during pregnancy and current evidence of obstetric, neonatal and pediatric outcome: a review article.

Maggen C, van Gerwen M, Van Calsteren K, Vandenbroucke T, Amant F.

Int J Gynecol Cancer. 2019 Jan 18. pii: ijgc-2018-000061. doi: 10.1136/ijgc-2018-000061. [Epub ahead of print]

PMID:
30659032
8.

MNK1/NODAL Signaling Promotes Invasive Progression of Breast Ductal Carcinoma In Situ.

Guo Q, Li VZ, Nichol JN, Huang F, Yang W, Preston SEJ, Talat Z, Lefrère H, Yu H, Zhang G, Basik M, Gonçalves C, Zhan Y, Plourde D, Su J, Torres J, Marques M, Habyan SA, Bijian K, Amant F, Witcher M, Behbod F, McCaffrey L, Alaoui-Jamali M, Giannakopoulos NV, Brackstone M, Postovit LM, Del Rincón SV, Miller WH Jr.

Cancer Res. 2019 Apr 1;79(7):1646-1657. doi: 10.1158/0008-5472.CAN-18-1602. Epub 2019 Jan 18.

9.

Development of Patient-Derived Tumor Xenograft Models.

Annibali D, Leucci E, Hermans E, Amant F.

Methods Mol Biol. 2019;1862:217-225. doi: 10.1007/978-1-4939-8769-6_15.

PMID:
30315470
10.

Cancer of the corpus uteri.

Amant F, Mirza MR, Koskas M, Creutzberg CL.

Int J Gynaecol Obstet. 2018 Oct;143 Suppl 2:37-50. doi: 10.1002/ijgo.12612.

PMID:
30306580
11.

Brief Report on 3-Weekly Paclitaxel Carboplatin Efficacy in Locally Advanced or Metastatic Squamous Vulvar Cancer.

Amant F, Nooij L, Annibali D, van Rompuy AS, Han S, van den Bulck H, Goffin F.

Gynecol Obstet Invest. 2018;83(6):620-626. doi: 10.1159/000487435. Epub 2018 Sep 18.

PMID:
30227411
12.

Effects of cancer treatment during pregnancy on fetal and child development.

Vandenbroucke T, Verheecke M, Fumagalli M, Lok C, Amant F.

Lancet Child Adolesc Health. 2017 Dec;1(4):302-310. doi: 10.1016/S2352-4642(17)30091-3. Epub 2017 Sep 29. Review.

PMID:
30169185
13.

Implementation of cancer treatment during pregnancy in daily practice: the important role of perinatologists.

de Geus KF, Maggen C, de Haan J, Amant F.

Oncotarget. 2018 Aug 7;9(61):31795-31796. doi: 10.18632/oncotarget.25841. eCollection 2018 Aug 7. No abstract available.

14.

Endometrial Stromal Sarcomas: A Revision of Their Potential as Targets for Immunotherapy.

Tuyaerts S, Amant F.

Vaccines (Basel). 2018 Aug 25;6(3). pii: E56. doi: 10.3390/vaccines6030056. Review.

15.

Patient-Derived Xenograft Models for Endometrial Cancer Research.

Moiola CP, Lopez-Gil C, Cabrera S, Garcia A, Van Nyen T, Annibali D, Fonnes T, Vidal A, Villanueva A, Matias-Guiu X, Krakstad C, Amant F, Gil-Moreno A, Colas E.

Int J Mol Sci. 2018 Aug 17;19(8). pii: E2431. doi: 10.3390/ijms19082431. Review.

16.

Modeling Endometrial Cancer: Past, Present, and Future.

Van Nyen T, Moiola CP, Colas E, Annibali D, Amant F.

Int J Mol Sci. 2018 Aug 9;19(8). pii: E2348. doi: 10.3390/ijms19082348. Review.

17.

Identification of nine new susceptibility loci for endometrial cancer.

O'Mara TA, Glubb DM, Amant F, Annibali D, Ashton K, Attia J, Auer PL, Beckmann MW, Black A, Bolla MK, Brauch H, Brenner H, Brinton L, Buchanan DD, Burwinkel B, Chang-Claude J, Chanock SJ, Chen C, Chen MM, Cheng THT, Clarke CL, Clendenning M, Cook LS, Couch FJ, Cox A, Crous-Bous M, Czene K, Day F, Dennis J, Depreeuw J, Doherty JA, Dörk T, Dowdy SC, Dürst M, Ekici AB, Fasching PA, Fridley BL, Friedenreich CM, Fritschi L, Fung J, García-Closas M, Gaudet MM, Giles GG, Goode EL, Gorman M, Haiman CA, Hall P, Hankison SE, Healey CS, Hein A, Hillemanns P, Hodgson S, Hoivik EA, Holliday EG, Hopper JL, Hunter DJ, Jones A, Krakstad C, Kristensen VN, Lambrechts D, Marchand LL, Liang X, Lindblom A, Lissowska J, Long J, Lu L, Magliocco AM, Martin L, McEvoy M, Meindl A, Michailidou K, Milne RL, Mints M, Montgomery GW, Nassir R, Olsson H, Orlow I, Otton G, Palles C, Perry JRB, Peto J, Pooler L, Prescott J, Proietto T, Rebbeck TR, Risch HA, Rogers PAW, Rübner M, Runnebaum I, Sacerdote C, Sarto GE, Schumacher F, Scott RJ, Setiawan VW, Shah M, Sheng X, Shu XO, Southey MC, Swerdlow AJ, Tham E, Trovik J, Turman C, Tyrer JP, Vachon C, VanDen Berg D, Vanderstichele A, Wang Z, Webb PM, Wentzensen N, Werner HMJ, Winham SJ, Wolk A, Xia L, Xiang YB, Yang HP, Yu H, Zheng W, Pharoah PDP, Dunning AM, Kraft P, De Vivo I, Tomlinson I, Easton DF, Spurdle AB, Thompson DJ.

Nat Commun. 2018 Aug 9;9(1):3166. doi: 10.1038/s41467-018-05427-7.

18.

2'-deoxy-2'-[18F] fluoro-D-glucose positron emission tomography, diffusion-weighted magnetic resonance imaging, and choline spectroscopy to predict the activity of cetuximab in tumor xenografts derived from patients with squamous cell carcinoma of the head and neck.

Mignion L, Schmitz S, Michoux N, Caignet X, Goebbels RM, Bol A, Neveu MC, Grégoire V, Duprez T, Lhommel R, Amant F, Hermans E, Jordan BF, Machiels JP.

Oncotarget. 2018 Jun 19;9(47):28572-28585. doi: 10.18632/oncotarget.25574. eCollection 2018 Jun 19.

19.

Genetic overlap between endometriosis and endometrial cancer: evidence from cross-disease genetic correlation and GWAS meta-analyses.

Painter JN, O'Mara TA, Morris AP, Cheng THT, Gorman M, Martin L, Hodson S, Jones A, Martin NG, Gordon S, Henders AK, Attia J, McEvoy M, Holliday EG, Scott RJ, Webb PM, Fasching PA, Beckmann MW, Ekici AB, Hein A, Rübner M, Hall P, Czene K, Dörk T, Dürst M, Hillemanns P, Runnebaum I, Lambrechts D, Amant F, Annibali D, Depreeuw J, Vanderstichele A, Goode EL, Cunningham JM, Dowdy SC, Winham SJ, Trovik J, Hoivik E, Werner HMJ, Krakstad C, Ashton K, Otton G, Proietto T, Tham E, Mints M, Ahmed S, Healey CS, Shah M, Pharoah PDP, Dunning AM, Dennis J, Bolla MK, Michailidou K, Wang Q, Tyrer JP, Hopper JL, Peto J, Swerdlow AJ, Burwinkel B, Brenner H, Meindl A, Brauch H, Lindblom A, Chang-Claude J, Couch FJ, Giles GG, Kristensen VN, Cox A, Zondervan KT, Nyholt DR, MacGregor S, Montgomery GW, Tomlinson I, Easton DF, Thompson DJ, Spurdle AB.

Cancer Med. 2018 May;7(5):1978-1987. doi: 10.1002/cam4.1445. Epub 2018 Apr 2.

20.

Severe Adverse Reaction to Vemurafenib in a Pregnant Woman with Metastatic Melanoma.

de Haan J, van Thienen JV, Casaer M, Hannivoort RA, Van Calsteren K, van Tuyl M, van Gerwen MM, Debeer A, Amant F, Painter RC.

Case Rep Oncol. 2018 Feb 15;11(1):119-124. doi: 10.1159/000487128. eCollection 2018 Jan-Apr.

Supplemental Content

Loading ...
Support Center